Future access to HIV vaccines: Report from a WHO-UNAIDS consultation, Geneva, 2-3 October 2000

AIDS

Volumn 15, Issue 7, 2001, Pages

  Esparza, J ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

HIV vaccines; Vaccine access; Vaccine delivery; Vaccine trials

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS RNA;

ARTICLE; CLINICAL TRIAL; HEALTH CARE FINANCING; HEALTH PROMOTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOGENICITY; INFECTION SENSITIVITY; PRIORITY JOURNAL; UNITED NATIONS; VACCINATION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

AIDS VACCINES; CLINICAL TRIALS, PHASE III; HIV INFECTIONS; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; SWITZERLAND; VACCINATION; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 0035805122     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200105040-00022     Document Type: Article

References (28)

1. Accelerating the development and future availability of HIV-1 vaccines: Why, when, where, and how?
2. Statistical methods for assessing differential vaccine protection against human immunodeficiency virus types
3. Design and interpretation of vaccine field studies
4. Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic vaccines 1996
5. Preventive HIV type I vaccine clinical trials: A regulatory perspective
6. Intent-to-treat analysis and preventive vaccine efficacy
7. Regulation and testing of Vaccines
8. Evaluating new vaccines for developing countries. Efficacy or effectiveness?
9. Role of the primary infection in epidemics of HIV infection in gay cohorts
10. An optimization model for influenza A epidemics
11. Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations
12. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas
13. Resource utilization for HIV/AIDS in Thailand, a pilot study
14. The potential demand for an AIDS vaccine in Thailand
15. Acceptability of HIV vaccine trials in high risk heterosexual cohorts in Mombasa, Kenya
16. Vaccinations in the third world: A consideration of community demand
17. Factors influencing the acceptance of hepatitis B vaccine by students in health disciplines in Ottawa
18. Patterns of vaccination acceptance
19. The 1978 Dutch polio epidemic: A sociological study of the motives for accepting or refusing vaccination
20. A small area analysis estimating the prevalence of addiction to opioids in Barcelona, 1993
21. Sistema integral de vigilancia epidemiólogica de I'HIV/sida a Cataluya (SIVES)
22. Development of bivalent rgp120 vaccines to prevent HIV type I infection
23. Initiation of a phase III efficacy trial of bivalent B/E rgp 120 HIV vaccine (AIDSVAXtmB/E) in Bangkok, Thailand
24. Successful recruitment and conduct of the first HIV vaccine efficacy trial in North America and Europe
25. (BVEG) Bangkok Vaccine Evaluation Group: Social harm monitoring among injecting drug users in a phase III HIV vaccine trail in Bangkok, Thailand - Preliminary results